Naunyn-Schmiedeberg's Archives of Pharmacology

, Volume 340, Issue 6, pp 610–616 | Cite as

[3H]Noradrenaline accumulation in cultured bovine adrenal medullary cells: modulation of accumulation by nicotine

  • Dennis B. McKay
Article

Summary

The mechanisms by which catecholamines are transported into adrenal medullary cells are not as well characterized as the high affinity catecholamine uptake system of sympathetic neurones. Therefore, we studied the accumulation of [3H]noradrenaline in 7–21 day old cultures of bovine adrenal cells. Cultured adrenal cells accumulate [3H]noradrenaline. The accumulation process has an apparent Km for noradrenaline of 0.47 μmol/l, is Na+ -dependent, and is inhibited by desipramine, (−)-noradrenaline and (−)adrenaline (IC50's, 0.007, 0.9 and 3.8 μmol/l, respectively). Other aromatic amines also inhibit accumulation with an order of potency, (+)-amphetamine ≥ dopamine > (−)-noradrenaline > (−)-adrenaline ≥ 5-hydroxytryptamine. Nicotine and other stimulants of catecholamine release (acetylcholine and depolarizing K+ concentrations) were found to inhibit [3H]noradrenaline accumulation. Reserpine pretreatment (72 h) or omission of calcium did not prevent nicotine's inhibitory effect on accumulation, but did reduce or inhibit nicotine-induced catecholamine release, suggesting that adrenal [3H]noradrenaline accumulation may be regulated by processes involved with stimulus-secretion coupling (e.g., sodium gradient and/or depolarization) which are independent of release. These results suggest that the catecholamine transport mechanisms of cultured bovine adrenal cells and sympathetic neurones are similar and may be regulated by secretory processes.

Key words

catecholamine release Cultured adrenal medullary cells Adrenal chromaffin cells Catecholamine uptake, noradrenaline accumulation Neuronal uptake Uptake 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Axelrod J, Weil-Malherbe H, Tomchick R (1959) The physiological disposition of 3H-epinephrine and its metabolite metanephrine. J Pharmacol Exp Ther 127:251–256Google Scholar
  2. Callingham BA (1967) The effects of imipramine and related compounds on the uptake of noradrenaline into sympathetic nerve endings. In: Garattini S, Dukes NMG (eds) Antidepressant drugs, Excerpta Medica International Congress Series No. 122. Excerpta Medica Foundation, Amsterdam, pp 35–43Google Scholar
  3. Dengler HJ, Michaelson IA, Spiegel HE, Titus E (1962) The uptake of labeled norepinephrine by isolated brain and other tissues of the cat. Int J Neuropharmacol 1:23–28Google Scholar
  4. Draskóczy PR, Trendelenburg U (1968) The uptake of 1- and dnorepinephrine by the isolated perfused rabbit heart in relation to the stereospecificity of the sensitizing action of cocaine. J Pharmacol Exp Ther 159:66–73Google Scholar
  5. Gillis CN, Paton DM (1967) Cation dependence of sympathetic neurotransmitter retention by slices of rat ventricle. Br J Pharmacol 29:309–318Google Scholar
  6. Graefe K-H, Bönisch H (1988) The transport of amines across the axonal membranes of noradrenergic and dopaminergic neurones. In: Trendelenburg U, Weiner N (eds) Catecholamines I. handbook exp pharmacol, vol 90/I. Springer, Berlin, Heidelberg New York, pp 193–245Google Scholar
  7. Harder R, Bönisch H (1985) Effects of monovalent ions on the transport of noradrenaline across the plasma membrane of neuronal cells (PC-12 cells). J Neurochem 45:1154–1162Google Scholar
  8. Holz RW, Deguchi T, Axelrod J (1974) Stimulation of serotonin N-acetyltransferase in pineal organ culture by drugs. J Neurochem 22:205–209Google Scholar
  9. Iversen LL (1975) Uptake processes for biogenic amines. In: Iversen LL, Iversen SD, Snyder SH (eds) Handbook of psychopharmacology, biochemistry of biogenic amines, vol 3. Plenum Press, New York, pp 381–442Google Scholar
  10. Johnson RG (1988) Accumulation of biogenic amines into chromaffin granules: a model for hormone and transmitter transport. Physiol Rev 68:232–307Google Scholar
  11. Kenigsberg RL, Trifaro JM (1980) Presence of a high affinity uptake system for catecholamines in cultured bovine adrenal chromaffin cells. Neuroscience 5:1547–1556Google Scholar
  12. Kilpatrick DL, Ledbetter FH, Carson KA, Kirshner AG, Slepetis R, Kirshner N (1980) Stability of bovine adrenal medullary cells in culture. J Neurochem 35:679–692Google Scholar
  13. McKay DB (1987) The high affinity catecholamine transport system of the cultured adrenal chromaffin cell. Pharmacologist 29:169Google Scholar
  14. McKay DB (1989) Structure-activity studies on the actions of taxol and related taxanes on primary cultures of adrenal medullary cells. J Pharmacol Exp Ther 248:1302–1307Google Scholar
  15. McKay DB, Schneider AS (1984) Selective inhibition of cholinergic receptor-mediated45Ca++ uptake and catecholamine secretion from adrenal chromaffin cells by taxol and vinblastine. J Pharmacol Exp Ther 231:102–108Google Scholar
  16. McKay DB, Hunter WB, Del Paggio D, Burnside JL (1988) Nicotinic receptor regulation of [3H]norepinephrine uptake in cultured adrenal medullary cells. Pharmacologist 30:54Google Scholar
  17. Patil PN, Miller DD, Trendelenburg U (1975) Molecular geometry and adrenergic drug activity. Pharmacol Rev 26:323–392Google Scholar
  18. Paton DM (1976) Characteristics of uptake of noradrenaline by adrenergic neurones. In: Paton DM (ed) The mechanism of neuronal and extraneuronal transport of catecholamines. Raven Press, New York, pp 49–66Google Scholar
  19. Philippu A, Matthaei H (1988) Transport and storage of catecholamines in vesicles. In: Trendelenburg U and Weiner N (eds) Catecholamines I. Handbook exp Pharmacol, vol 90/I. Springer, Berlin Heidelberg New York, pp 1–42Google Scholar
  20. Role LW, Perlman RL (1983) Catecholamine uptake into isolated adrenal chromaffin cells: inhibition of uptake by acetylcholine. Neuroscience 10:987–996Google Scholar
  21. Schneider AS, Herz R, Rosenheck K (1977) Stimulus-secretion coupling in chromaffin cells isolated from bovine adrenal medulla. Proc Natl Acad Sci USA 74:5036–5040Google Scholar
  22. Trendelenburg U (1986) Modulation of uptake2 of3H-(±)-isoprenaline by isoprenaline-induced depolarization of rat salivary gland cells. Naunyn-Schmiedeberg's Arch Pharmacol 334: 388–392Google Scholar
  23. Trendelenburg U (1987) The membrane potential of vascular smooth muscle appears to modulate uptake2 of3H-isoprenaline. Naunyn-Schmiedeberg's Arch Pharmacol 336:33–36Google Scholar
  24. Trifaro JM, Lee RWH (1980) Morphological characteristics and stimulus-secretion coupling in bovine adrenal chromaffin cell cultures. Neuroscience 5:1533–1546Google Scholar
  25. Ungar A, Phillips JH (1983) Regulation of the adrenal medulla. Physiol Rev 63:787–843Google Scholar
  26. Ungell A-L, Graefe K-H (1987) Failure of K+ to affect potency of inhibitors of the neuronal noradrenaline carrier in the rat vas deferens. Naunyn-Schmiedeberg's Arch Pharmacol 335:250–254Google Scholar

Copyright information

© Springer-Verlag 1989

Authors and Affiliations

  • Dennis B. McKay
    • 1
  1. 1.College of Pharmacy, Division of PharmacologyThe Ohio State UniversityColumbusUSA

Personalised recommendations